Skip to content
OpenCapital
Get started

Xperi XPER Concentration Risk %

Concentration Risk % at other companies

Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
93.1%-5.3pp
Heartland Express logo
Heartland ExpressHTLD
32%+6.0pp
Enovix Corporation logo
Enovix CorporationENVX
83%+36.0pp
Weis Markets logo
Weis MarketsWMK
100%0.0pp
Innoviva, Inc. logo
Innoviva, Inc.INVA
36%+7.0pp
Strattec Security logo
Strattec SecuritySTRT
0.5%0.0pp

Segments

By geography

See full
US And Canada45%—
Asia Pacific41%—
Europe Middle East And Africa9%—
Other Asia5%-16.7%

By product

See full
Advertising2.5%—
Hardware Products2.5%—
Nre Services2.5%—

Other financials

Income statement

See full
Revenue$114.2M+0.2%
Gross profit$83.3M-1.3%
Operating income$2.2M+113%
Net income-$7.8M+57.4%
EPS (diluted)-$0.17+58.5%

Balance sheet

See full
Cash & equivalents$70.4M-20.0%
Total debt$67.6M-10.3%
Total equity$429.1M+6.1%
Total assets$606.9M-4.2%

Cash flow

See full
Operating cash flow-$18.0M+19.1%
CapEx$1.1M+3.7%
Free cash flow-$19.1M+18.0%

Valuation

See full
Market cap$371.69M+5.1%
Enterprise value$368.92M+8.2%
P/S0.8×+0.1×

Profitability

See full
Gross margin71.5%-5.3pp
Operating margin-5.6%-2.1pp
Net margin-10.2%—
FCF margin-6.6%—

Returns & leverage

See full
Return on equity-21.8%-8.9pp
Debt / equity0.2×0.0×
Current ratio2.4×+0.1×